Now showing items 1-3 of 3

  • Aggregation of Staphylococcus aureus following treatment with the antibacterial flavonol galangin. 

    Cushnie, T. P. Tim; Hamilton, V. E. S.; Chapman, D. G.; Taylor, P. W.; Lamb, Andrew (Wiley https://doi.org/10.1111/j.1365-2672.2007.03393.x, 2007-06-13)
    CUSHNIE, T.P.T., HAMILTON, V.E.S., CHAPMAN, D.G., TAYLOR, P.W. and LAMB, A.J. 2007. Aggregation of Staphylococcus aureus following treatment with the antibacterial flavonol galangin. Journal of applied microbiology [online], 103(5), pages 1562-1567. Available from: https://doi.org/10.1111/j.1365-2672.2007.03393.x
    The flavonol galangin, an antimicrobial constituent of the traditional medicines propolis and Helichrysum aureonitens, is being assessed as part of an ongoing investigation into the antibacterial activity of flavonoids. ...
  • Colistin causes profound morphological alteration but minimal cytoplasmic membrane perforation in populations of Escherichia coli and Pseudomonas aeruginosa. 

    O'Driscoll, Noelle H.; Cushnie, T. P. Tim; Matthews, Kerr H.; Lamb, Andrew (Springer https://doi.org/10.1007/s00203-018-1485-3, 2018-02-08)
    O'DRISCOLL, N.H., CUSHNIE, T.P.T., MATTHEWS, K.H. and LAMB, A.J. 2018. Colistin causes profound morphological alteration but minimal cytoplasmic membrane perforation in populations of Escherichia coli and Pseudomonas aeruginosa. Archives of microbiology [online], First Online. Available from: https://doi.org/10.1007/s00203-018-1485-3
    Whilst colistin (polymyxin E) represents the last mainstream treatment option for multi-drug resistant Gram-negative pathogens, details of its mechanism of action remain to be fully resolved. In this study, the effects ...
  • Morphological and ultrastructural changes in bacterial cells as an indicator of antibacterial mechanism of action. 

    Cushnie, T. P. Tim; O'Driscoll, Noelle H.; Lamb, Andrew (Springer https://doi.org/10.1007/s00018-016-2302-2, 2016-07-28)
    CUSHNIE, T.P.T., O'DRISCOLL, N.H. and LAMB, A.J. 2016. Morphological and ultrastructural changes in bacterial cells as an indicator of antibacterial mechanism of action. Cellular and molecular life sciences [online], 73(23), pages 4471-4492. Available from: https://doi.org/10.1007/s00018-016-2302-2
    Efforts to reduce the global burden of bacterial disease and contend with escalating bacterial resistance are spurring innovation in antibacterial drug and biocide development and related technologies such as photodynamic ...